Usana Health Sciences India Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
- Paid Up Capital ₹ 33.75 Cr
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 59.19%
- Ebitda 100.56%
- Net Worth -26.06%
- Total Assets 43.86%
About Usana Health Sciences India
Usana Health Sciences India Private Limited (UHSIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 09 January 2018 (Seven years and one month 4 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 33.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Usana Health Sciences India Private Limited India is Sapna Bharti as COMPANY SECRETARY. Gary Hekking, Peter Foukas, and Puneet Madan serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2018FTC328184
-
Company No.
328184
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
09 Jan 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Usana Health Sciences India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Madan
|
Managing Director | 14-Mar-2023 | Current |
|
Sapna Bharti
|
Company Secretary | 10-Jul-2024 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gary Hekking
|
Director | 09-Jan-2018 | Current |
|
Peter Foukas
|
Director | 22-Jan-2019 | Current |
Financial Performance of Usana Health Sciences India.
Usana Health Sciences India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 59.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Usana Health Sciences India?
In 2022, Usana Health Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Usana Health Sciences India?
Unlock and access historical data on people associated with Usana Health Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Usana Health Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usana Health Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
